Silence Therapeutics (SLN) EBITDA Margin (2024 - 2026)
Silence Therapeutics (SLN) reported EBITDA Margin of 3729.15% for Q1 2026, up 1627719.0% on a YoY basis from N/an in Q1 2025, and up 89.82% sequentially from 36650.0% in Q4 2025.
Silence Therapeutics (SLN) EBITDA Margin (2024 - 2026) Analysis & Trends
Silence Therapeutics (SLN) has 3 years of EBITDA Margin data on file, last reported at 3729.15% in Q1 2026.
- For the quarter ending Q1 2026, EBITDA Margin rose 1627719.0% year-over-year to 3729.15%; the trailing twelve-month figure through Mar 2026 stood at 9345.05% (down 903456.0% YoY), and the FY2025 full-year result was 16292.84%, down 1614647.0% from the prior year.
- EBITDA Margin rose to 3729.15% in Q1 2026, from 36650.0% in the prior quarter.
- In the past five years, EBITDA Margin ranged from a high of 17.2% in Q4 2024 to a low of 36650.0% in Q4 2025.
- A 3-year average of 10285.29% and a median of 3729.15% in 2026 frame the typical range for EBITDA Margin.
- Across the five-year window, EBITDA Margin sank 3663280 bps in 2025 and surged 1627719 bps in 2026, its largest moves.
- Tracing SLN's EBITDA Margin over 3 years: stood at 17.2% in 2024, then slumped by 213004 bps to 36650.0% in 2025, then surged by 90 bps to 3729.15% in 2026.
- Business Quant data shows SLN's EBITDA Margin at 3729.15% in Q1 2026, 36650.0% in Q4 2025, and 16505.66% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 16.51% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 38.10% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 17.83% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 31.68% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Silence Therapeutics | 1.62 Bn | 1.49 Bn | 411,000.00 | -3,729.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,729.15% |
| Dec 31, 2025 | -36,650.00% |
| Sep 30, 2025 | -16,505.66% |
| Jun 30, 2025 | -10,697.77% |
| Mar 31, 2025 | -20,006.34% |
| Dec 31, 2024 | -17.20% |
| Sep 30, 2024 | -2,002.47% |
| Jun 30, 2024 | -2,923.50% |
| Mar 31, 2024 | -35.55% |